LMAT Insider Trading
Insider Ownership Percentage: 10.79%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $10,888,005.35
LeMaitre Vascular Insider Trading History Chart
This chart shows the insider buying and selling history at LeMaitre Vascular by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
LeMaitre Vascular Share Price & Price History
Current Price: $83.83
Price Change: ▼ Price Decrease of -1.28 (-1.50%)
As of 03/18/2025 10:54 AM ET
LeMaitre Vascular Insider Trading History
LeMaitre Vascular Institutional Trading History
Data available starting January 2016
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Read More on LeMaitre Vascular
Today's Range
Now: $83.83
52 Week Range
Now: $83.83
Volume
3,046 shs
Average Volume
143,120 shs
Market Capitalization
$1.89 billion
P/E Ratio
45.81
Dividend Yield
1.01%
Beta
0.89
Who are the company insiders with the largest holdings of LeMaitre Vascular?
Who are the major institutional investors of LeMaitre Vascular?
Which major investors are selling LeMaitre Vascular stock?
Within the previous quarter, LMAT stock was sold by these institutional investors:
- Conestoga Capital Advisors LLC
- F M Investments LLC
- DF Dent & Co. Inc.
- Ameriprise Financial Inc.
- Russell Investments Group Ltd.
- D. E. Shaw & Co. Inc.
- Ranger Investment Management L.P.
- Summit Creek Advisors LLC
Within the last year, company insiders that have sold LeMaitre Vascular company stock include:
- George W Lemaitre (CEO)
- David B Roberts (Director)
- John A Roush (Director)
- Joseph P Pellegrino Jr (CFO)
Learn More investors selling LeMaitre Vascular stock.
Which major investors are buying LeMaitre Vascular stock?
In the last quarter, LMAT stock was acquired by institutional investors including:
- Raymond James Financial Inc.
- Raymond James Financial Inc.
- Rockefeller Capital Management L.P.
- Segall Bryant & Hamill LLC
- Invesco Ltd.
- Millennium Management LLC
- JPMorgan Chase & Co.
- Monashee Investment Management LLC
